Another Year to Celebrate Advances in Clinical Hematology

por Mohty, Mohamad, Melo, Junia V.
Publicado 2023

Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib

por Chuah, Charles, Melo, Junia V
Publicado 2009

One Year into the COVID-19 Pandemic

por Mohty, Mohamad, Melo, Junia V.
Publicado 2021

Intracellular Retention of ABL Kinase Inhibitors Determines Commitment to Apoptosis in CML Cells

por Lipka, Daniel B., Wagner, Marie-Christine, Dziadosz, Marek, Schnöder, Tina, Heidel, Florian, Schemionek, Mirle, Melo, Junia V., Kindler, Thomas, Müller-Tidow, Carsten, Koschmieder, Steffen, Fischer, Thomas
Publicado 2012

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia

por Cerny-Reiterer, Sabine, Meyer, Renata A., Herrmann, Harald, Peter, Barbara, Gleixner, Karoline V., Stefanzl, Gabriele, Hadzijusufovic, Emir, Pickl, Winfried F., Sperr, Wolfgang R., Melo, Junia V., Maeda, Hiroshi, Jäger, Ulrich, Valent, Peter
Publicado 2014

The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells

por Stefanzl, Gabriele, Berger, Daniela, Cerny-Reiterer, Sabine, Blatt, Katharina, Eisenwort, Gregor, Sperr, Wolfgang R., Hoermann, Gregor, Lind, Karin, Hauswirth, Alexander W., Bettelheim, Peter, Sill, Heinz, Melo, Junia V., Jäger, Ulrich, Valent, Peter
Publicado 2017

A Target-Disease Network Model of Second-Generation BCR-ABL Inhibitor Action in Ph+ ALL

por Rix, Uwe, Colinge, Jacques, Blatt, Katharina, Gridling, Manuela, Remsing Rix, Lily L., Parapatics, Katja, Cerny-Reiterer, Sabine, Burkard, Thomas R., Jäger, Ulrich, Melo, Junia V., Bennett, Keiryn L., Valent, Peter, Superti-Furga, Giulio
Publicado 2013

Imatinib-resistance associated with BCR-ABL upregulation is dependent on HIF-1α-induced metabolic reprogramming

por Zhao, Fangping, Mancuso, Anthony, Bui, Thi V., Tong, Xuemei, Gruber, Joshua J., Swider, Cezary R., Sanchez, Patricia V, Lum, Julian J., Sayed, Nabil, Melo, Junia V., Perl, Alexander E., Carroll, Martin, Tuttle, Stephen W., Thompson, Craig B.
Publicado 2010

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia

por Blatt, Katharina, Menzl, Ingeborg, Eisenwort, Gregor, Cerny-Reiterer, Sabine, Herrmann, Harald, Herndlhofer, Susanne, Stefanzl, Gabriele, Sadovnik, Irina, Berger, Daniela, Keller, Alexandra, Hauswirth, Alexander, Hoermann, Gregor, Willmann, Michael, Rülicke, Thomas, Sill, Heinz, Sperr, Wolfgang R., Mannhalter, Christine, Melo, Junia V., Jäger, Ulrich, Sexl, Veronika, Valent, Peter
Publicado 2018

Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition

por Mitchell, Rebecca, Hopcroft, Lisa E M, Baquero, Pablo, Allan, Elaine K, Hewit, Kay, James, Daniel, Hamilton, Graham, Mukhopadhyay, Arunima, O’Prey, Jim, Hair, Alan, Melo, Junia V, Chan, Edmond, Ryan, Kevin M, Maguer-Satta, Véronique, Druker, Brian J, Clark, Richard E, Mitra, Subir, Herzyk, Pawel, Nicolini, Franck E, Salomoni, Paolo, Shanks, Emma, Calabretta, Bruno, Holyoake, Tessa L, Helgason, G Vignir
Publicado 2017

A kinase-independent role for CDK8 in BCR-ABL1(+) leukemia

por Menzl, Ingeborg, Zhang, Tinghu, Berger-Becvar, Angelika, Grausenburger, Reinhard, Heller, Gerwin, Prchal-Murphy, Michaela, Edlinger, Leo, Knab, Vanessa M., Uras, Iris Z., Grundschober, Eva, Bauer, Karin, Roth, Mareike, Skucha, Anna, Liu, Yao, Hatcher, John M., Liang, Yanke, Kwiatkowski, Nicholas P., Fux, Daniela, Hoelbl-Kovacic, Andrea, Kubicek, Stefan, Melo, Junia V., Valent, Peter, Weichhart, Thomas, Grebien, Florian, Zuber, Johannes, Gray, Nathanael S., Sexl, Veronika
Publicado 2019